Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Alprolix (Coagulation Factor IX (Recombinant), Fc Fusion Protein) is prescribed to adults and children with hemophilia B to treat bleeding episodes, manage bleeding during surgery, and to help reduce the incidence of bleeding episodes.
Alprolix is given via a vein (intravenously).
Fact Table | |
---|---|
Formula | C2916H4484N782O836S29 |
License | FDA approved |
Bioavailability | Not applicable (intravenous administration) |
Legal status | Prescription only |
Chemical Name | Coagulation factor IX (recombinant), Fc fusion protein |
Elimination half-life | Approximately 82 hours |
Dosage (Strength) | 250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU per vial |
Pregnancy | Consult a healthcare provider |
Brands | Alprolix |
Protein binding | Not significantly bound to plasma proteins |
PubChem CID | Not available |
MedlinePlus | a614022 |
ChEBI | Not available |
ATC code | B02BD04 |
DrugBank | DB00020 |
KEGG | D10262 |
Routes of administration | Intravenous |
Your doctor will decide your course of treatment, including Alprolix dosing. A healthcare provider will give Alprolix via an intravenous infusion. Any questions or concerns may be referred to your doctor.
Coagulation Factor IX (Recombinant), Fc Fusion Protein is the active ingredient in Alprolix.
Alprolix should not be administered to patients who are allergic to any of Alprolix’s ingredients.
Alprolix side effects include but are not limited to headache, abnormal sensation in the mouth, and pain in your side with blood in the urine. Contact your doctor right away if you have worrisome or persistent side effects.
Talk to your doctor about Alprolix.
Alprolix. Waltham, MA: Bioverativ Therapeutics Inc.; 2023.